165
Views
162
CrossRef citations to date
0
Altmetric
Research Article

Three-Month Prevalence Rates of Gastrointestinal Symptoms and the Influence of Demographic Factors: Results from the Domestic/International Gastroenterology Surveillance Study (DIGEST)

Pages 20-28 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (11)

Frederik Hvid-Jensen, Rikke B Nielsen, Lars Pedersen, Peter Funch-Jensen, Asbjørn Mohr Drewes, Finn B Larsen & Reimar W Thomsen. (2013) Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting. Clinical Epidemiology 5, pages 493-499.
Read now
Josep Darbà, Lisette Kaskens, Pedro Plans, Jose Ignasi Elizalde, Montserrat Coma, Rosario Cuomo, Luigi Santoiemma & Jan Geldmacher. (2011) Epidemiology and societal costs of gastroesophageal reflux disease and Barrett’s syndrome in Germany, Italy and Spain. Expert Review of Pharmacoeconomics & Outcomes Research 11:2, pages 225-232.
Read now
Christine Bucknall, Andrew Stanton, Graham Miller, Neil Rajoriya, Suresh Babu & John Mackenzie. (2009) The Impact of Normalization of Esophageal Acid Profile by Incremental Protein Pump Inhibitors Dosing in Difficult Asthma Patients with Proven Gastro-esophageal Acid Reflux. Journal of Asthma 46:5, pages 506-511.
Read now
Yoshihisa Urita, Toshiyasu Watanabe, Hiroki Ota, Motohide Iwata, Yosuke Sasaki, Tadashi Maeda, Takamasa Ishii, Makie Nanami, Asuka Nakayama, Hirohito Kato, Kazuo Hike, Noriko Hara, Masaki Sanaka, Yoko Nagai, Shuji Watanabe, Kazushige Nakanishi, Hitoshi Nakajima & Motonobu Sugimoto. (2008) High prevalence of gastroesophageal reflux symptoms in patients with both acute and nonacute cough. International Journal of General Medicine 1, pages 59-63.
Read now
Ana Ruigómez, Luis Alberto García Rodríguez, Mari‐Ann Wallander, Saga Johansson & John Dent. (2006) Comparison of gastro-oesophageal reflux disease and heartburn diagnoses in UK primary care. Current Medical Research and Opinion 22:9, pages 1661-1668.
Read now
Mette Wildner-Christensen, Jane Møller Hansen & Ove B. Schaffalitzky De Muckadell. (2006) Risk factors for dyspepsia in a general population: Non-steroidal anti-inflammatory drugs, cigarette smoking and unemployment are more important than Helicobacter pylori infection. Scandinavian Journal of Gastroenterology 41:2, pages 149-154.
Read now
Franco Pacini, Carlo Calabrese, Livio Cipolletta, Mario D’Ayala Valva, Antonio Russo, Vincenzo Savarino & Sergio Vigneri. (2005) Burden of illness in Italian patients with gastro-oesophageal reflux disease. Current Medical Research and Opinion 21:4, pages 495-502.
Read now
Ching-Liang Lu, Hui-Chu Lang, Full-Young Chang, Chih-Yen Chen, Jiing-Chyuan Luo, Sun-Sang Wang & Shou-Dong Lee. (2005) Prevalence and health/social impacts of functional dyspepsia in Taiwan: A study based on the Rome Criteria Questionnaire Survey assisted by endoscopic exclusion among a physical check-up population. Scandinavian Journal of Gastroenterology 40:4, pages 402-411.
Read now
J. G. P. Tijssen. (1999) Representativeness and Response Rates from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scandinavian Journal of Gastroenterology 34:231, pages 15-19.
Read now

Articles from other publishers (151)

Younghee Choe. (2024) Obesity and Upper Gastrointestinal Diseases. The Korean Journal of Gastroenterology 83:3, pages 81-86.
Crossref
Eri Momma, Saori Kanai, Yoshimasa Hoshikawa, Mai Koeda, Tomohide Tanabe, Shintaro Hoshino, Noriyuki Kawami, Mitsuru Kaise & Katsuhiko Iwakiri. (2022) Smaller CO2 injection volume and lower gastric pressure induce bothersome symptoms in drug-resistant functional dyspepsia patients with less frequent belching. PLOS ONE 17:7, pages e0271456.
Crossref
Yasunori Yamamoto, Shinya Furukawa, Junichi Watanabe, Aki Kato, Katsunori Kusumoto, Eiji Takeshita, Yoshio Ikeda, Naofumi Yamamoto, Katsuhiko Kohara, Yuka Saeki & Yoichi Hiasa. (2022) Association Between Body Mass Index and Functional Dyspepsia in Young Japanese People. Journal of Neurogastroenterology and Motility 28:2, pages 276-282.
Crossref
Nayoung Kim. 2022. Sex/Gender-Specific Medicine in the Gastrointestinal Diseases. Sex/Gender-Specific Medicine in the Gastrointestinal Diseases 95 113 .
Eri Momma, Mai Koeda, Tomohide Tanabe, Saori Kanai, Yoshimasa Hoshikawa, Shintaro Hoshino, Noriyuki Kawami, Mitsuru Kaise & Katsuhiko Iwakiri. (2021) New endoscopic method for gastric hypersensitivity testing: Pilot study. JGH Open 5:5, pages 614-621.
Crossref
Fabrizio Bert, Erika Pompili, Giuseppina Lo Moro, Alessio Corradi, Angelica Sagrawa Caro, Maria Rosaria Gualano & Roberta Siliquini. (2020) Prevalence of gastro‐oesophageal reflux symptoms: An Italian cross‐sectional survey focusing on knowledge and attitudes towards lifestyle and nutrition. International Journal of Clinical Practice 75:3.
Crossref
Larisa Vladimirovna Bychkova, Anastasia Sergeevna Zhuravleva, Mikhail Grigorevich Rodoman, Olga Yurievna Markina & Malika Mansurovna Irkabaeva. (2021) Difficulties in diagnosing GERD in the absence of esophageal manifestations. Clinical observation. Hirurg (Surgeon):1, pages 25-32.
Crossref
Kyohei Ogisu, Atsuhiro Masuda, Tsuyoshi Fujita, Yukinao Yamazaki, Masao Kobayashi, Shuichi Terao, Tsuyoshi Sanuki, Akihiko Okada, Masayasu Adachi, Yoshifumi Arisaka, Haruka Miyazaki, Hayato Yoshinaka, Hiromu Kutsumi, Eiji Umegaki & Yuzo Kodama. (2020) Influence of sex on the association between body mass index and frequency of upper gastrointestinal symptoms. JGH Open 4:5, pages 937-944.
Crossref
V. T. Ivashkin, I. V. Maev, A. S. Trukhmanov, T. L. Lapina, O. A. Storonova, O. V. Zayratyants, O. B. Dronova, Yu. A. Kucheryavyy, S. S. Pirogov, R. G. Sayfutdinov, Yu. P. Uspenskiy, A. A. Sheptulin, D. N. Andreev & D. E. Rumyantseva. (2020) Recommendations of the Russian Gastroenterological Association in Diagnosis and Treatment of Gastroesophageal Reflux Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 30:4, pages 70-97.
Crossref
Brigida Barberio, Sanjiv Mahadeva, Christopher J. Black, Edoardo V. Savarino & Alexander C. Ford. (2020) Systematic review with meta‐analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteria. Alimentary Pharmacology & Therapeutics 52:5, pages 762-773.
Crossref
Young Sun Kim & Nayoung Kim. (2020) Functional Dyspepsia: A Narrative Review With a Focus on Sex-Gender Differences. Journal of Neurogastroenterology and Motility 26:3, pages 322-334.
Crossref
Jorabar Singh Nirwan, Syed Shahzad Hasan, Zaheer-Ud-Din Babar, Barbara R. Conway & Muhammad Usman Ghori. (2020) Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis. Scientific Reports 10:1.
Crossref
Lokesh Agrawal, Mustafa Korkutata, Sunil Kumar Vimal, Manoj Kumar Yadav, Sanjib Bhattacharyya & Takashi Shiga. (2020) Therapeutic potential of serotonin 4 receptor for chronic depression and its associated comorbidity in the gut. Neuropharmacology 166, pages 107969.
Crossref
Ahmed T. Chatila, Minh Thu T. Nguyen, Timothy Krill, Russell Roark, Mohammad Bilal & Gabriel Reep. (2020) Natural history, pathophysiology and evaluation of gastroesophageal reflux disease. Disease-a-Month 66:1, pages 100848.
Crossref
Tsuyoshi Fujita, Eiji Umegaki, Atsuhiro Masuda, Masao Kobayashi, Yukinao Yamazaki, Shuichi Terao, Akihiko Okada, Tsuyoshi Sanuki, Masayasu Adachi, Manabu Murakami, Hiromu Kutsumi & Takeshi Azuma. (2019) Differences in Both Gender and Age of Upper Gastrointestinal Symptoms in Health Checkup Subjects健診受診者における上腹部症状の性別と年齢による違い. Health Evaluation and Promotion 46:2, pages 266-272.
Crossref
Suhas Chandran, Rajesh Raman, M. Kishor & H. P. Nandeesh. (2019) The effectiveness of mindfulness meditation in relief of symptoms of depression and quality of life in patients with gastroesophageal reflux disease. Indian Journal of Gastroenterology 38:1, pages 29-38.
Crossref
Pradeep K. Siddappa & John W. Birk. 2019. Healthy Aging. Healthy Aging 67 79 .
Manuel Monroy, Miguel A. Ruiz, Javier Rejas & Javier Soto. (2018) Mapping of the Gastrointestinal Short Form Questionnaire (GSF-Q) into EQ-5D-3L and SF-6D in patients with gastroesophageal reflux disease. Health and Quality of Life Outcomes 16:1.
Crossref
Ibnu Fajariyadi Hantoro, Ari Fahrial Syam, Endang Mudjaddid, Siti Setiati & Murdani Abdullah. (2018) Factors associated with health-related quality of life in patients with functional dyspepsia. Health and Quality of Life Outcomes 16:1.
Crossref
A. Gomi, K. Yamaji, O. Watanabe, M. Yoshioka, K. Miyazaki, Y. Iwama & Y. Urita. (2018) Bifidobacterium bifidum YIT 10347 fermented milk exerts beneficial effects on gastrointestinal discomfort and symptoms in healthy adults: A double-blind, randomized, placebo-controlled study. Journal of Dairy Science 101:6, pages 4830-4841.
Crossref
Özlem ÖZER ÇAKIR, Ahmet ÇİZMECİOĞLU, Murat BIYIK, Sami ÇİFÇİ, Hüseyin ATASEVEN, Hakkı POLAT & Ali DEMİR. (2018) Konya il merkezinde gastroözofageal reflü hastalığı prevalansıPrevalence of gastroesophageal reflux in the central province of Konya. Akademik Gastroenteroloji Dergisi 17:1, pages 2-11.
Crossref
Leonardo H Eusebi, Raguprakash Ratnakumaran, Yuhong Yuan, Masoud Solaymani-Dodaran, Franco Bazzoli & Alexander C Ford. (2018) Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut 67:3, pages 430-440.
Crossref
Paolo Quitadamo, Letizia Zenzeri, Enza Mozzillo, Irene Cuccurullo, Alba Rocco, Adriana Franzese, Gerardo Nardone & Annamaria Staiano. (2018) Gastric Emptying Time, Esophageal pH-Impedance Parameters, Quality of Life, and Gastrointestinal Comorbidity in Obese Children and Adolescents. The Journal of Pediatrics 194, pages 94-99.
Crossref
Noriaki Manabe & Ken Haruma. 2018. The Rise of Acid Reflux in Asia. The Rise of Acid Reflux in Asia 37 49 .
Yoon Jin Choi, Young Soo Park, Nayoung Kim, Yong Sung Kim, Sun Min Lee, Dong Ho Lee & Hyun Chae Jung. (2017) Gender differences in ghrelin, nociception genes, psychological factors and quality of life in functional dyspepsia. World Journal of Gastroenterology 23:45, pages 8053-8061.
Crossref
Ulrik Deding, Christian Torp-Pedersen & Henrik Bøggild. (2017) Perceived stress as a risk factor for dyspepsia: a register-based cohort study. European Journal of Gastroenterology & Hepatology 29:5, pages 560-567.
Crossref
Gillian Watson, James O’Hara, Paul Carding, Jan Lecouturier, Deborah Stocken, Tony Fouweather & Janet Wilson. (2016) TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial. Trials 17:1.
Crossref
Hai-Yun Wang, Kondarapassery Balakumaran Leena, Amelie Plymoth, Maria-Pia Hergens, Li Yin, Kotacherry Trivikrama Shenoy & Weimin Ye. (2016) Prevalence of gastro-esophageal reflux disease and its risk factors in a community-based population in southern India. BMC Gastroenterology 16:1.
Crossref
F. Huerta-Iga, M.V. Bielsa-Fernández, J.M. Remes-Troche, M.A. Valdovinos-Díaz & J.L. Tamayo-de la Cuesta. (2016) Diagnosis and treatment of gastroesophageal reflux disease: recommendations of the Asociación Mexicana de Gastroenterología. Revista de Gastroenterología de México (English Edition) 81:4, pages 208-222.
Crossref
F. Huerta-Iga, M.V. Bielsa-Fernández, J.M. Remes-Troche, M.A. Valdovinos-Díaz & J.L. Tamayo-de la Cuesta. (2016) Diagnóstico y tratamiento de la enfermedad por reflujo gastroesofágico: recomendaciones de la Asociación Mexicana de Gastroenterología. Revista de Gastroenterología de México 81:4, pages 208-222.
Crossref
Toshihiro Nishizawa, Tatsuhiro Masaoka & Hidekazu Suzuki. (2016) Functional Dyspepsia: Pathogenesis, Diagnosis, and Treatment. Journal of General and Family Medicine 17:3, pages 204-210.
Crossref
Luzia Baumeler, Eleni Papakonstantinou, Branislava Milenkovic, Alicia Lacoma, Renaud Louis, Joachim G. Aerts, Tobias Welte, Konstantinos Kostikas, Francesco Blasi, Wim Boersma, Antoni Torres, Gernot G.U. Rohde, Lucas Boeck, Janko Rakic, Andreas Scherr, Michael Tamm & Daiana Stolz. (2016) Therapy with proton‐pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD. Respirology 21:5, pages 883-890.
Crossref
Qin Xu, Wei Zhang, Tianyi Zhang, Ruijie Zhang, Yanfang Zhao, Yuan Zhang, Yibin Guo, Rui Wang, Xiuqiang Ma & Jia He. (2016) Zero-Inflated Models for Identifying Relationships Between Body Mass Index and Gastroesophageal Reflux Symptoms: A Nationwide Population-Based Study in China. Digestive Diseases and Sciences 61:7, pages 1986-1995.
Crossref
Kate Napthali, Natasha Koloski, Marjorie M Walker & Nicholas J Talley. (2016) Women and Functional Dyspepsia. Women's Health 12:2, pages 241-250.
Crossref
Marta Barcelo, Angel Alvarez Sanchez, Raquel Garcia Sanchez, Manuel Diaz-Rubio & Enrique Rey. (2016) Weight Gain and Somatization are Associated With the Onset of Gastroesophageal Reflux Diseases. Journal of Clinical Gastroenterology 50:3, pages 202-207.
Crossref
Satoshi Shinozaki, Hiroyuki Osawa, Hirotsugu Sakamoto, Yoshikazu Hayashi, Alan Kawarai Lefor & Hironori Yamamoto. (2016) The effect of acotiamide on epigastric pain syndrome and postprandial distress syndrome in patients with functional dyspepsia. The Journal of Medical Investigation 63:3.4, pages 230-235.
Crossref
Kai Fu, Liu Yang, Qiu-Fen Wang, Fu-Xu Zhan, Bin Wang, Qian Yang, Zhi-Jia Ma & Geng-Xiu Zheng. (2015) A Three-Step Synthesis of Acotiamide for the Treatment of Patients with Functional Dyspepsia. Organic Process Research & Development 19:12, pages 2006-2011.
Crossref
Hayley A. Hutchings, Wai-Yee Cheung, Ian T. Russell, Dharmaraj Durai, Laith Alrubaiy & John G. Williams. (2015) Psychometric development of the Gastrointestinal Symptom Rating Questionnaire (GSRQ) demonstrated good validity. Journal of Clinical Epidemiology 68:10, pages 1176-1183.
Crossref
T. Amano, H. Ariga, A. Kurematsu, S. Yamato, S. Morioka, A. Masaka, M. Kanazawa & S. Fukudo. (2015) Effect of 5‐hydroxytryptamine receptor 4 agonist mosapride on human gastric accommodation. Neurogastroenterology & Motility 27:9, pages 1303-1309.
Crossref
M. Vardi, B. L. Cryer, M. Cohen, A. Lanas, T. J. Schnitzer, P. Lapuerta, M. A. Goldsmith, L. Laine, G. Doros, Y. Liu, A. I. McIntosh, C. P. Cannon & D. L. Bhatt. (2015) The effects of proton pump inhibition on patient‐reported severity of dyspepsia when receiving dual anti‐platelet therapy with clopidogrel and low‐dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial. Alimentary Pharmacology & Therapeutics 42:3, pages 365-374.
Crossref
Alexander C Ford, Avantika Marwaha, Ruchit Sood & Paul Moayyedi. (2015) Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut 64:7, pages 1049-1057.
Crossref
Toshihiko Tomita, Toshinari Yasuda, Hideo Oka, Shuichi Terao, Eitastu Arai, Tadayuki Oshima, Hirokazu Fukui, Kazutoshi Hori, Jiro Watari & Hiroto Miwa. (2015) Atypical symptoms and health‐related quality of life of patients with asymptomatic reflux esophagitis. Journal of Gastroenterology and Hepatology 30:S1, pages 19-24.
Crossref
Hiroto Miwa, Motoyasu Kusano, Tomiyasu Arisawa, Tadayuki Oshima, Mototsugu Kato, Takashi Joh, Hidekazu Suzuki, Kazunari Tominaga, Koji Nakada, Akihito Nagahara, Seiji Futagami, Noriaki Manabe, Akio Inui, Ken Haruma, Kazuhide Higuchi, Koji Yakabi, Michio Hongo, Naomi Uemura, Yoshikazu Kinoshita, Kentaro Sugano & Tooru Shimosegawa. (2015) Evidence-based clinical practice guidelines for functional dyspepsia. Journal of Gastroenterology 50:2, pages 125-139.
Crossref
Alexander C. Ford & Nicholas J. Talley. 2014. GI Epidemiology. GI Epidemiology 158 171 .
Amir Soumekh, Felice H. Schnoll-Sussman & Philip O. Katz. (2014) Reflux and Acid Peptic Diseases in the Elderly. Clinics in Geriatric Medicine 30:1, pages 29-41.
Crossref
Hirohiko Shinkai, Katsunori Iijima, Tomoyuki Koike, Kenichiro Nakagawa, Ryuhei Maejima, Hiroyuki Endo, Nobuyuki Ara, Naoki Asano, Akira Imatani, Shuichi Ohara & Tooru Shimosegawa. (2014) Calcium Carbonate Breath Test for Non-Invasive Estimation of Gastric Acid Secretion. The Tohoku Journal of Experimental Medicine 232:4, pages 255-261.
Crossref
Benoît Lévesque, Marie-Christine Gervais, Pierre Chevalier, Denis Gauvin, Elhadji Anassour-Laouan-Sidi, Suzanne Gingras, Nathalie Fortin, Geneviève Brisson, Charles Greer & David Bird. (2014) Prospective study of acute health effects in relation to exposure to cyanobacteria. Science of The Total Environment 466-467, pages 397-403.
Crossref
Lydie Izakovicova Holla, Petra Borilova Linhartova, Barbara Hrdlickova, Filip Marek, Jiri Dolina, Vladimir Rihak & Zdenek Kala. (2013) Haplotypes of the IL-1 gene cluster are associated with gastroesophageal reflux disease and Barrett’s esophagus. Human Immunology 74:9, pages 1161-1169.
Crossref
Jo Gamble, Margot Skinner & Sara Jaeger. (2013) Psychological well‐being and the role of food in healthy middle‐aged and older women who have experienced acute gastrointestinal disturbances. British Food Journal 115:5, pages 711-726.
Crossref
Wataru Iwai, Yasuhiko Abe, Katsunori Iijima, Tomoyuki Koike, Kaname Uno, Naoki Asano, Akira Imatani & Tooru Shimosegawa. (2012) Gastric hypochlorhydria is associated with an exacerbation of dyspeptic symptoms in female patients. Journal of Gastroenterology 48:2, pages 214-221.
Crossref
Tomoari Kamada, Yoshinori Fujimura, Kensuke Gotoh, Hiroshi Imamura, Noriaki Manabe, Hiroaki Kusunoki, Kazuhiko Inoue, Akiko Shiotani, Jiro Hata & Ken Haruma. (2013) A Study on the Efficacy of Proton Pump Inhibitors in Helicobacter pylori-Negative Primary Care Patients with Dyspepsia in Japan. Gut and Liver 7:1, pages 16-22.
Crossref
Hirohiko Shinkai, Tomoyuki Koike, Miki Shimada, Kenichiro Nakagawa, Katsunori Iijima, Yotaro Matsumoto, Masamitsu Maekawa, Nariyasu Mano & Tooru Shimosegawa. (2013) Influence of the Meal and Genotype of CYP2C19 on the Pharmacokinetics of Proton Pump Inhibitors in Healthy Japanese Subjects. Pharmacology & Pharmacy 04:06, pages 502-509.
Crossref
Hidekazu Suzuki, Toshihiro Nishizawa & Toshifumi Hibi. (2013) 3. Functional Dyspepsia3.機能性ディスペプシア. Nihon Naika Gakkai Zasshi 102:1, pages 63-69.
Crossref
Marco D. Gulewitsch, Paul Enck, Juliane Schwille-Kiuntke, Katja Weimer & Angelika A. Schlarb. (2013) Mental Strain and Chronic Stress among University Students with Symptoms of Irritable Bowel Syndrome. Gastroenterology Research and Practice 2013, pages 1-8.
Crossref
Kouichi Sakurai, Akihito Nagahara, Kazuhiko Inoue, Junichi Akiyama, Katsuhiro Mabe, Junichi Suzuki, Yasuki Habu, Akihiro Araki, Tsuyoshi Suzuki, Katsuaki Satoh, Haruhiko Nagami, Ryosaku Harada, Nobuo Tano, Masayasu Kusaka, Yasuhiko Fujioka, Toshikatsu Fujimura, Nobuyuki Shigeto, Tsuneyo Oumi, Jun Miwa, Hiroto Miwa, Kazuma Fujimoto, Yoshikazu Kinoshita & Ken Haruma. (2012) Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS). BMC Gastroenterology 12:1.
Crossref
N. Pandeya, A. C. Green & D. C. Whiteman. (2012) Prevalence and determinants of frequent gastroesophageal reflux symptoms in the Australian community. Diseases of the Esophagus 25:7, pages 573-583.
Crossref
Hee Youn Choi, Yook-Hwan Noh, Seok-Joon Jin, Yo Han Kim, Mi-Jo Kim, Hyeryoung Sung, Seong Bok Jang, Sung Jae Lee, Kyun-Seop Bae & Hyeong-Seok Lim. (2012) Bioavailability and Tolerability of Combination Treatment With Revaprazan 200 mg + Itopride 150 mg: A Randomized Crossover Study in Healthy Male Korean Volunteers. Clinical Therapeutics 34:9, pages 1999-2010.
Crossref
Cristina Dacoll, Verónica Umpierre, Giselle Tomasso, Gustavo Saona, Alicia Alemán, Maria Luisa Cafferata, Miguel Villa-Gómez & Henry Cohen. (2012) Prevalencia de la enfermedad por reflujo gastroesofágico en Uruguay. Gastroenterología y Hepatología 35:7, pages 460-467.
Crossref
Paolo Quitadamo, Roberta Buonavolontà, Erasmo Miele, Paola Masi, Paola Coccorullo & Annamaria Staiano. (2012) Total and Abdominal Obesity Are Risk Factors for Gastroesophageal Reflux Symptoms in Children. Journal of Pediatric Gastroenterology and Nutrition 55:1, pages 72-75.
Crossref
G. D. Eslick. (2011) Gastrointestinal symptoms and obesity: a meta‐analysis. Obesity Reviews 13:5, pages 469-479.
Crossref
Linda Bjork Olafsdottir, Hallgrimur Gudjonsson, Heidur Hrund Jonsdottir, Einar Bjornsson & Bjarni Thjodleifsson. (2012) Natural history of functional gastrointestinal disorders: Comparison of two longitudinal population-based studies. Digestive and Liver Disease 44:3, pages 211-217.
Crossref
Eun Young Lee, Mi Suk Mun, Seon Hye Lee & Ho Soon Michelle Cho. (2011) Perceived stress and gastrointestinal symptoms in nursing students in Korea: A cross-sectional survey. BMC Nursing 10:1.
Crossref
Yoshikazu Kinoshita, Kyoichi Adachi, Michio Hongo & Ken Haruma. (2011) Systematic review of the epidemiology of gastroesophageal reflux disease in Japan. Journal of Gastroenterology 46:9, pages 1092-1103.
Crossref
Tobias Zuchelli & Scott E. Myers. (2011) Gastrointestinal Issues in the Older Female Patient. Gastroenterology Clinics of North America 40:2, pages 449-466.
Crossref
Praveen Kumar Sharma, Vineet Ahuja, Kaushal Madan, Saurabh Gupta, Akshay Raizada & Mahesh Prakash Sharma. (2010) Prevalence, severity, and risk factors of symptomatic gastroesophageal reflux disease among employees of a large hospital in Northern India. Indian Journal of Gastroenterology 30:3, pages 128-134.
Crossref
Hiroto Miwa, Jiro Watari, Hirokazu Fukui, Tadayuki Oshima, Toshihiko Tomita, Jun Sakurai, Takashi Kondo & Takayuki Matsumoto. (2011) Current understanding of pathogenesis of functional dyspepsia. Journal of Gastroenterology and Hepatology 26:s3, pages 53-60.
Crossref
Y. Kinoshita, K. Ashida & M. Hongo. (2011) Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease. Alimentary Pharmacology & Therapeutics 33:2, pages 213-224.
Crossref
Ai Fujikawa, Takeshi Suzue, Fumihiko Jitsunari & Tomohiro Hirao. (2010) Evaluation of health-related quality of life using EQ-5D in Takamatsu, Japan. Environmental Health and Preventive Medicine 16:1, pages 25-35.
Crossref
Luigi Gatta, Paul Moayyedi, Cesare Tosetti, Nimish Vakil, Enzo Ubaldi, Patrizia Barsanti, Giulia Fiorini, Valentina Castelli, Carlo Gargiulo, Paolo Lucarini, Maurizio Lera, Enkleda Kajo, Francesco Di Mario & Dino Vaira. (2010) A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire. Internal and Emergency Medicine 5:6, pages 501-506.
Crossref
Mónica Tafalla, Javier Nuevo, Javier Zapardiel & Javier P. Gisbert. (2010) Estudio de síntomas relevantes y atención clínica en la enfermedad por reflujo gastroesofágico en atención primaria en España. Gastroenterología y Hepatología 33:7, pages 490-497.
Crossref
K. Matsueda, M. Hongo, J. Tack, H. Aoki, Y. Saito & H. Kato. (2010) Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage. Neurogastroenterology & Motility 22:6, pages 618-e173.
Crossref
Max Schmulson, Mopelola Adeyemo, Gabriela Gutiérrez-Reyes, Luis Charúa-Guindic, Blanca Farfán-Labonne, Feggy Ostrosky-Solis, Adriana Díaz-Anzaldúa, Laura Medina & Lin Chang. (2010) Differences in Gastrointestinal Symptoms According to Gender in Rome II Positive IBS and Dyspepsia in a Latin American Population. American Journal of Gastroenterology 105:4, pages 925-932.
Crossref
Serhat Bor, Gul Kitapcioglu, Zeynep Aytemur Solak, Muhittin Ertilav & Munevver Erdinc. (2010) Prevalence of gastroesophageal reflux disease in patients with asthma and chronic obstructive pulmonary disease. Journal of Gastroenterology and Hepatology 25:2, pages 309-313.
Crossref
Jung Hwan Oh. (2010) Health-Related Quality of Life Issues in Gastroesophageal Reflux Disease. The Korean Journal of Gastroenterology 55:2, pages 85.
Crossref
Vesna Brzacki, Aleksandar Nagorni, Dragan Mihailovic, Suzana Raicevic-Sibinovic & Bojan Mladenovic. (2010) Analysis of the grade of esophagitis, chromendoscopical and histological findings of esophagus in patients with gastroesophageal reflux disease before and after the therapy. Vojnosanitetski pregled Military Medical and Pharmaceutical Journal of Serbia 67:12, pages 991-997.
Crossref
Joel E. Richter & Frank K. Friedenberg. 2010. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 705 726.e6 .
Hiroto Miwa, A Nagahara, K Tominaga, T Yokoyama, Y Sawada, K Inoue, Kiyoshi Ashida, T Fukuchi, M Hojo, H Yamashita, T Tomita, K Hori & T Oshima. (2009) Efficacy of the 5-HT1A Agonist Tandospirone Citrate in Improving Symptoms of Patients With Functional Dyspepsia: A Randomized Controlled Trial. The American Journal of Gastroenterology 104:11, pages 2779-2787.
Crossref
Kazutoshi Hori, Takayuki Matsumoto & Hiroto Miwa. (2009) Analysis of the Gastrointestinal Symptoms of Uninvestigated Dyspepsia and Irritable Bowel Syndrome. Gut and Liver 3:3, pages 192-196.
Crossref
Julio Ponce, Belén Beltrán, Marta Ponce, Javier Zapardiel, Vicente Ortiz, Onofre Vegazo & Javier Nuevo. (2009) Impact of gastroesophageal reflux disease on the quality of life of Spanish patients: the relevance of the biometric factors and the severity of symptoms. European Journal of Gastroenterology & Hepatology 21:6, pages 620-629.
Crossref
Yasuhiro Fujiwara & Tetsuo Arakawa. (2009) Epidemiology and clinical characteristics of GERD in the Japanese population. Journal of Gastroenterology 44:6, pages 518-534.
Crossref
Sophie P. Toya & George E. Tzelepis. (2009) The many faces of scleroderma sine scleroderma: a literature review focusing on cardiopulmonary complications. Rheumatology International 29:8, pages 861-868.
Crossref
Wei‐Qing Chen, Tze‐Wai Wong & Tak‐Sun Yu. (2009) Direct and interactive effects of occupational stress and coping on ulcer‐like symptoms among Chinese male off‐shore oil workers. American Journal of Industrial Medicine 52:6, pages 500-508.
Crossref
Elena Sánchez Jiménez & Javier Rodríguez Díaz. (2009) Repercusiones sintomáticas de la técnica dog en extensión bilateral sobre D5/D6 en pacientes dispépticos. Osteopatía Científica 4:2, pages 47-54.
Crossref
Hiroaki Kusunoki, Masayasu Kusaka, Soichiro Kido, Ryo Yamauchi, Yoshinori Fujimura, Yasuyuki Watanabe, Michio Kobori, Hiroto Miwa, Toshihiko Tomita, Yongmin Kin, Kazutoshi Hori, Nobuo Tano, Kenji Sugimoto, Yoshihiro Nakamura, Kazuma Fujimoto, Noriko Oza, Aki Matsunobu, Naofumi Ono, Seisuke Fuyuno, Yoshikazu Kinoshita, Kyoichi Adachi, Mika Yuki, Tomoo Fujisawa & Ken Haruma. (2009) Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis. Journal of Gastroenterology 44:4, pages 261-270.
Crossref
Paresh Kamat, Sijin Wen, Jeffrey Morris & Sharmila Anandasabapathy. (2009) Exploring the Association Between Elevated Body Mass Index and Barrett's Esophagus: A Systematic Review and Meta-Analysis. The Annals of Thoracic Surgery 87:2, pages 655-662.
Crossref
Ichiro Yoshikawa, Makiko Nagato, Masahiro Yamasaki, Keiichiro Kume & Makoto Otsuki. (2009) Long-term treatment with proton pump inhibitor is associated with undesired weight gain. World Journal of Gastroenterology 15:38, pages 4794.
Crossref
Rodrigo Torres-Quevedo, Carlos Manterola, Antonio Sanhueza, Luis Bustos, Viviana Pineda & Manuel Vial. (2009) Diagnostic properties of a symptoms scale for diagnosing reflux esophagitis. Journal of Clinical Epidemiology 62:1, pages 97-101.
Crossref
A. Ruiz-García, F.J. Gordillo-López, E. Arranz-Martínez, L.E. Morales-Cobos & C. Ferrari-Ferrando. (2008) Valoración de la implantación en Atención Primaria de la guía de práctica clínica ERGE. SEMERGEN - Medicina de Familia 34:9, pages 439-443.
Crossref
O. CHASSANY, G. HOLTMANN, J. MALAGELADA, U. GEBAUER, H. DOERFLER & K. DEVAULT. (2008) Systematic review: health‐related quality of life (HRQOL) questionnaires in gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 27:11, pages 1053-1070.
Crossref
Hatsushi Yamagishi, Tomoyuki Koike, Shuichi Ohara, Toru Horii, Ryousuke Kikuchi, Shigeyuki Kobayashi, Yasuhiko Abe, Katsunori Iijima, Akira Imatani, Kaori Suzuki, Takanori Hishinuma, Junichi Goto & Tooru Shimosegawa. (2008) Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole. World Journal of Gastroenterology 14:15, pages 2406.
Crossref
Hatsushi Yamagishi, Tomoyuki Koike, Shuichi Ohara, Toru Horii, Ryousuke Kikuchi, Shigeyuki Kobayashi, Yasuhiko Abe, Katsunori Iijima, Akira Imatani, Kaori Suzuki, Takanori Hishinuma, Junichi Goto & Tooru Shimosegawa. (2008) Early effects of Lansoprazole orally disintegrating tablets on intragastric pH in CYP2C19 extensive metabolizers. World Journal of Gastroenterology 14:13, pages 2049.
Crossref
Hatsushi Yamagishi, Tomoyuki Koike, Shuichi Ohara, Shigeyuki Kobayashi, Ken Ariizumi, Yasuhiko Abe, Katsunori Iijima, Akira Imatani, Yoshifumi Inomata, Katsuaki Kato, Daisuke Shibuya, Shigemitsu Aida & Tooru Shimosegawa. (2008) Prevalence of gastroesophageal reflux symptoms in a large unselected general population in Japan. World Journal of Gastroenterology 14:9, pages 1358.
Crossref
J. Romero Vzquez, M. Gmez Parr, J.M. Herreras Gutirrez, P. Moreno Santos & F. Oltra Hostalet. (2008) Manejo general y extrahospitalario del paciente con enfermedad por reflujo gastroesof?gico, la disfagia y el dolor tor?cico de causa esof?gica. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 10:1, pages 41-47.
Crossref
Shannon E Majowicz, Julie Horrocks & Kathryn Bocking. (2007) Demographic determinants of acute gastrointestinal illness in Canada: a population study. BMC Public Health 7:1.
Crossref
Jorgen Urnes, Per G. Farup, Stian Lydersen & Hermod Petersen. (2007) Patient education in gastro-oesophageal reflux disease: a randomized controlled trial. European Journal of Gastroenterology & Hepatology 19:12, pages 1104-1110.
Crossref
&NA;. (2007) Geriatric GERD: Maximizing Outcomes for a Unique Patient Population. Journal of the American Academy of Physician Assistants 20:10, pages 3-13.
Crossref
H. MIWA, K. NAKAJIMA, K. YAMAGUCHI, K. FUJIMOTO, S. J. O. VELDHUYZEN VAN ZANTEN, Y. KINOSHITA, K. ADACHI, H. KUSUNOKI & K. HARUMA. (2007) Generation of dyspeptic symptoms by direct acid infusion into the stomach of healthy Japanese subjects. Alimentary Pharmacology & Therapeutics 26:2, pages 257-264.
Crossref
Kenneth R. DeVault. (2008) Presbyesophagus: Do modern data support the concept?. Current GERD Reports 1:2, pages 84-90.
Crossref
Y. KINOSHITA. (2007) Review article: management issues in acid‐related disorders in the elderly. Alimentary Pharmacology & Therapeutics Symposium Series 3:2, pages 21-26.
Crossref
Giovanni Cammarota, Giovanna Masala, Rossella Cianci, Domenico Palli, Pasquale Capaccio, Antonio Schindler, Lucio Cuoco, Jacopo Galli, Enzo Ierardi, Oreste Cannizzaro, Michele Caselli, Maria P. Dore, Benedetta Bendinelli & Giovanni Gasbarrini. (2007) Reflux Symptoms in Professional Opera Choristers. Gastroenterology 132:3, pages 890-898.
Crossref
A. FRASER, B. C. DELANEY, A. C. FORD, M. QUME & P. MOAYYEDI. (2007) The Short‐Form Leeds Dyspepsia Questionnaire validation study. Alimentary Pharmacology & Therapeutics 25:4, pages 477-486.
Crossref
John M. Connors. 2007. xPharm: The Comprehensive Pharmacology Reference. xPharm: The Comprehensive Pharmacology Reference 1 7 .
Hirohiko Iwasaki, Masayoshi Kajimura, Satoshi Osawa, Shigeru Kanaoka, Takahisa Furuta, Mutsuhiro Ikuma & Akira Hishida. (2006) A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus. Journal of Gastroenterology 41:11, pages 1076-1087.
Crossref
Sarah N. Flier & Suzanne Rose. (2006) Is Functional Dyspepsia of Particular Concern in Women? A Review of Gender Differences in Epidemiology, Pathophysiologic Mechanisms, Clinical Presentation, and Management. American Journal of Gastroenterology 101, pages S644-S653.
Crossref
Sarah N. Flier & Suzanne Rose. (2006) Is Functional Dyspepsia of Particular Concern in Women? A Review of Gender Differences in Epidemiology, Pathophysiologic Mechanisms, Clinical Presentation, and Management. The American Journal of Gastroenterology 101:s3, pages S644-S653.
Crossref
Douglas A Corley & Ai Kubo. (2006) Body Mass Index and Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis. The American Journal of Gastroenterology 101:11, pages 2619-2628.
Crossref
Enrique Rey, Cristina Moreno Elola-Olaso, Fernando Rodr??guez-Artalejo, G. Richard Locke & Manuel D??az-Rubio. (2006) Prevalence of atypical symptoms and their association with typical symptoms of gastroesophageal reflux in Spain. European Journal of Gastroenterology & Hepatology 18:9, pages 969-975.
Crossref
M. NOCON, T. KEIL & S. N. WILLICH. (2006) Prevalence and sociodemographics of reflux symptoms in Germany – results from a national survey. Alimentary Pharmacology & Therapeutics 23:11, pages 1601-1605.
Crossref
Brian C. Jacobson, Samuel C. Somers, Charles S. Fuchs, Ciarán P. Kelly & Carlos A. CamargoJr.Jr.. (2006) Body-Mass Index and Symptoms of Gastroesophageal Reflux in Women. New England Journal of Medicine 354:22, pages 2340-2348.
Crossref
Vicente Ortiz, Marta Ponce, Alberto Fernández, Beatriz Martínez, Jose Luis Ponce, Vicente Garrigues & Julio Ponce. (2012) Value of Heartburn for Diagnosing Gastroesophageal Reflux Disease in Severely Obese Patients. Obesity 14:4, pages 696-700.
Crossref
Sushil K. Ahlawat, Maria Teresa Cuddihy & G. Richard LockeIIIIII. (2006) Gender-related differences in dyspepsia: A qualitative systematic review. Gender Medicine 3:1, pages 31-42.
Crossref
Enrique Rey, Cristina Moreno-Elola-Olaso, Fernando Rodriguez Artalejo, G. Richard Locke & Manuel Diaz-Rubio. (2006) Association between Weight Gain and Symptoms of Gastroesophageal Reflux in the General Population. The American Journal of Gastroenterology 101:2, pages 229-233.
Crossref
S. N. WILLICH, M. NOCON, M. KULIG, D. JASPERSEN, J. LABENZ, W. MEYER‐SABELLEK, M. STOLTE, T. LIND & P. MALFERTHEINER. (2006) Cost‐of‐disease analysis in patients with gastro‐oesophageal reflux disease and Barrett's mucosa. Alimentary Pharmacology & Therapeutics 23:3, pages 371-376.
Crossref
Kyoichi Adachi, Yoshinobu Matsumori, Tomoo Fujisawa, Tomoari Kamada, Masayasu Kusaka, Tsuneyo Ohumi, Ryuichi Iwakiri, Kanako Yamaguchi, Akiko Danjo, Kazutoshi Hori, Toshihiko Tomita, Takamasa Hayashi, Ken Haruma, Kazuma Fujimoto, Hiroto Miwa & Yoshikazu Kinoshita. (2006) Symptom Diversity of Patients with Reflux Esophagitis: Effect of Omeprazole Treatment. Journal of Clinical Biochemistry and Nutrition 39:1, pages 46-54.
Crossref
J. PONCE, O. VEGAZO, B. BELTRÁN, J. JIMÉNEZ, J. ZAPARDIEL, D. CALLE & J. M. PIQUÉ. (2005) Prevalence of gastro‐oesophageal reflux disease in Spain and associated factors. Alimentary Pharmacology & Therapeutics 23:1, pages 175-184.
Crossref
Jean-François Bretagne, Bruno Richard-Molard, Charles Honnorat, Agnès Caekaert & Philippe Barthélemy. (2006) Le reflux gastro-œsophagien dans la population générale française. La Presse Médicale 35:1, pages 23-31.
Crossref
Yasuhiro Fujiwara, Ai Machida, Yoko Watanabe, Masatsugu Shiba, Kazunari Tominaga, Toshio Watanabe, Nobuhide Oshitani, Kazuhide Higuchi & Tetsuo Arakawa. (2005) Association Between Dinner-to-Bed Time and Gastro-Esophageal Reflux Disease. The American Journal of Gastroenterology 100:12, pages 2633-2636.
Crossref
Mariko Hojo, Hiroto Miwa, Tetsuji Yokoyama, Toshifumi Ohkusa, Akihito Nagahara, Masato Kawabe, Daisuke Asaoka, Yuko Izumi & Nobuhiro Sato. (2005) Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review. Journal of Gastroenterology 40:11, pages 1036-1042.
Crossref
Atsushi Muramatsu, Takeshi Azuma, Tomoyuki Okuda, Satoko Satomi, Masahiro Ohtani, Soshoku lee, Hiroyuki Suto, Yoshiyuki Ito, Yukinao Yamazaki & Masaru Kuriyama. (2005) Association between interleukin-1β-511C/T polymorphism and reflux esophagitis in Japan. Journal of Gastroenterology 40:9, pages 873-877.
Crossref
P. MOAYYEDI & A. T. R. AXON. (2005) Review article: gastro‐oesophageal reflux disease – the extent of the problem. Alimentary Pharmacology & Therapeutics 22:s1, pages 11-19.
Crossref
J. C. CHIOCCA, J. A. OLMOS, G. B. SALIS, L. O. SOIFER, R. HIGA & M. MARCOLONGO. (2005) Prevalence, clinical spectrum and atypical symptoms of gastro‐oesophageal reflux in Argentina: a nationwide population‐based study. Alimentary Pharmacology & Therapeutics 22:4, pages 331-342.
Crossref
S. K. AHLAWAT, G. RICHARD LOCKE, A. L. WEAVER, S. A. FARMER, B. P. YAWN & N. J. TALLEY. (2005) Dyspepsia consulters and patterns of management: a population‐based study. Alimentary Pharmacology & Therapeutics 22:3, pages 251-259.
Crossref
SHEN L LIM, WEE TECK GOH, JEN‐MAI J LEE, TZE PIN NG & KHEK‐YU HO. (2005) Changing prevalence of gastroesophageal reflux with changing time: Longitudinal study in an Asian population. Journal of Gastroenterology and Hepatology 20:7, pages 995-1001.
Crossref
Y. Fujiwara, K. Higuchi, H. Nebiki, S. Chono, H. Uno, K. Kitada, H. Satoh, K. Nakagawa, K. Kobayashi, K. Tominaga, T. Watanabe, N. Oshitani & T. Arakawa. (2005) Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non‐erosive gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 21:s2, pages 10-18.
Crossref
Serhat Bor, Aliye Mandiracioglu, Gul Kitapcioglu, Canan Caymaz-Bor & Richard J. Gilbert. (2005) Gastroesophageal Reflux Disease in a Low-Income Region in Turkey. The American Journal of Gastroenterology 100:4, pages 759-765.
Crossref
Yasuhiro Fujiwara, Kazuhide Higuchi, Masatsugu Shiba, Kazuki Yamamori, Yoko Watanabe, Eiji Sasaki, Kazunari Tominaga, Toshio Watanabe, Nobuhide Oshitani & Tetsuo Arakawa. (2005) Differences in Clinical Characteristics between Patients with Endoscopy-Negative Reflux Disease and Erosive Esophagitis in Japan. The American Journal of Gastroenterology 100:4, pages 754-758.
Crossref
Mitchell S. Cappell. (2005) Clinical presentation, diagnosis, and management of gastroesophageal reflux disease. Medical Clinics of North America 89:2, pages 243-291.
Crossref
Adam Fraser, Brendan Delaney & Paul Moayyedi. (2005) Symptom-Based Outcome Measures for Dyspepsia and GERD Trials: A Systematic Review. The American Journal of Gastroenterology 100:2, pages 442-452.
Crossref
YASUHIRO FUJIWARA, KAZUHIDE HIGUCHI, YOKO WATANABE, MASATSUGU SHIBA, TOSHIO WATANABE, KAZUNARI TOMINAGA, NOBUHIDE OSHITANI, TAKAYUKI MATSUMOTO, HIDEKI NISHIKAWA & TETSUO ARAKAWA. (2009) Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. Journal of Gastroenterology and Hepatology 20:1, pages 26-29.
Crossref
J. Melzer, W. Rösch, J. Reichling, R. Brignoli & R. Saller. (2004) Meta‐analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast). Alimentary Pharmacology & Therapeutics 20:11-12, pages 1279-1287.
Crossref
B. C. Delaney. (2004) Review article: prevalence and epidemiology of gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 20:s8, pages 2-4.
Crossref
T. Frieling. (2004) Antirefluxtherapie?mehr als S�ureblockade?Reflux disease management?more than acid reduction?. Der Internist 45:12, pages 1364-1369.
Crossref
W. M. Wong, K. C. Lai, K. F. Lam, W. M. Hui, J. Q. Huang, H. H. X. Xia, W. H. C. Hu, C. L. K. Lam, C. K. Chan, S. K. Lam & B. C. Y. Wong. (2004) Onset and disappearance of reflux symptoms in a Chinese population: a 1‐year follow‐up study. Alimentary Pharmacology & Therapeutics 20:7, pages 803-812.
Crossref
J. Y. Kang. (2004) Geographical and ethnic differences in gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 20:7, pages 705-717.
Crossref
WAI‐MAN WONG, PAUL LIM & BENJAMIN CHUN‐YU WONG. (2004) Clinical practice pattern of gastroenterologists, primary care physicians, and otolaryngologists for the management of GERD in the Asia–Pacific region: The FAST survey. Journal of Gastroenterology and Hepatology 19:s3.
Crossref
WAI‐MAN WONG & RONNIE FASS. (2004) Extraesophageal and atypical manifestations of GERD. Journal of Gastroenterology and Hepatology 19:s3.
Crossref
WAI‐MAN WONG & BENJAMIN CHUN‐YU WONG. (2004) Definition and diagnosis of gastroesophageal reflux disease. Journal of Gastroenterology and Hepatology 19:s3.
Crossref
A. Muramatsu, T. Azuma, T. Okajima, M. Ohtani, M. Dojo, Y. Yamazaki & M. Kuriyama. (2004) Evaluation of treatment for gastro‐oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro‐oesophageal reflux disease and Helicobacter pylori infection in Japan. Alimentary Pharmacology & Therapeutics 20:s1, pages 102-106.
Crossref
WAI‐MAN WONG, WAI‐MO HUI & BENJAMIN CHUN‐YU WONG. (2004) Asia–Pacific consensus on gastroesophageal reflux disease. Journal of Gastroenterology and Hepatology 19:4, pages 353-356.
Crossref
A. Balboa Rodrguez, A. Perell Juan & F. Mearin Manrique. (2004) Protocolo de actuaci?n en la dispepsia funcional. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 9:2, pages 127-130.
Crossref
M. Diaz‐Rubio, C. Moreno‐Elola‐Olaso, E. Rey, G. R. LockeIIIIII & F. Rodriguez‐Artalejo. (2003) Symptoms of gastro‐oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Alimentary Pharmacology & Therapeutics 19:1, pages 95-105.
Crossref
W. M. Wong, K. C. Lai, K. F. Lam, W. M. Hui, W. H. C. Hu, C. L. K. Lam, H. H. X. Xia, J. Q. Huang, C. K. Chan, S. K. Lam & B. C. Y. Wong. (2003) Prevalence, clinical spectrum and health care utilization of gastro‐oesophageal reflux disease in a Chinese population: a population‐based study. Alimentary Pharmacology & Therapeutics 18:6, pages 595-604.
Crossref
Liam Murray, Brian Johnston, Athene Lane, Ian Harvey, Jenny Donovan, Prakash Nair & Richard Harvey. (2003) Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project. International Journal of Epidemiology 32:4, pages 645-650.
Crossref
Shigemi Nakajima & Takanori Hattori. (2003) Active and Inactive Gastroesophageal Reflux Diseases Related to Helicobacter pylori Therapy . Helicobacter 8:4, pages 279-293.
Crossref
Linda M. Schachter, John Dixon, Robert J. Pierce & Paul O’Brien. (2003) Severe Gastroesophageal Reflux Is Associated With Reduced Carbon Monoxide Diffusing Capacitya. Chest 123:6, pages 1932-1938.
Crossref
Karna Dev Bardhan. (2003) Intermittent and on-Demand Use of Proton Pump Inhibitors in The Management of Symptomatic Gastroesophageal Reflux Disease. American Journal of Gastroenterology 98, pages S40-S48.
Crossref
Vincenzo Stanghellini, Fabrizio De Ponti, Roberto De Giorgio, Giovanni Barbara, Cesare Tosetti & Roberto Corinaldesi. (2003) New Developments in the Treatment of Functional Dyspepsia. Drugs 63:9, pages 869-892.
Crossref
JJ. Mascort, M. Marzo, P. Alonso-Coello, M. Barenys, F. Carballo, M. Fernández, LJ. Ferrándiz, X. Bonfill & JM. Piqué. (2003) Guía de práctica clínica sobre el manejo del paciente con dispepsia. Gastroenterología y Hepatología 26:9, pages 571-613.
Crossref
D. P. Hirsch, G. N. J. Tytgat & G. E. E. Boeckxstaens. (2002) Transient lower oesophageal sphincter relaxations—a pharmacological target for gastro‐oesophageal reflux disease?. Alimentary Pharmacology & Therapeutics 16:1, pages 17-26.
Crossref
M. Marzo, P. Alonso, X. Bonfill, M. Fernández, J. Fernández, G. Martínez, F. Mearín, J.J. Mascort, J.M. Piqué, J. Ponce & M. Sáez. (2002) Guía de práctica clínica sobre el manejo del paciente con enfermedad por reflujo gastroesofágico (ERGE). Gastroenterología y Hepatología 25:2, pages 85-110.
Crossref
Nicholas J Talley, Steve Fullerton, Ola Junghard & Ingela Wiklund. (2001) Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. American Journal of Gastroenterology 96:7, pages 1998-2004.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.